These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 19477910)
81. The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease. Schmidt AM; Sahagan B; Nelson RB; Selmer J; Rothlein R; Bell JM Curr Opin Investig Drugs; 2009 Jul; 10(7):672-80. PubMed ID: 19579173 [TBL] [Abstract][Full Text] [Related]
82. Influence of the Pro12Ala polymorphism of PPAR-gamma on age at onset and sRAGE levels in Alzheimer's disease. Yao L; Li K; Zhang L; Yao S; Piao Z; Song L Brain Res; 2009 Sep; 1291():133-9. PubMed ID: 19631630 [TBL] [Abstract][Full Text] [Related]
83. Glyoxalase I Glu111Ala polymorphism in patients with breast cancer. Germanová A; Germanová A; Tesarová P; Jáchymová M; Zvára K; Zima T; Kalousová M Cancer Invest; 2009 Jul; 27(6):655-60. PubMed ID: 19452310 [TBL] [Abstract][Full Text] [Related]
84. Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes. Tchaikovski V; Olieslagers S; Böhmer FD; Waltenberger J Circulation; 2009 Jul; 120(2):150-9. PubMed ID: 19564559 [TBL] [Abstract][Full Text] [Related]
85. Mild methionine excess does not affect thymidylate synthesis or inflammation markers expression in human aortic endothelial cells. Achón M; Alonso-Aperte E; Varela-Moreiras G; Selhub J Ann Nutr Metab; 2009; 54(1):28-34. PubMed ID: 19246892 [TBL] [Abstract][Full Text] [Related]
86. Small Molecule Inhibition of Ligand-Stimulated RAGE-DIAPH1 Signal Transduction. Manigrasso MB; Pan J; Rai V; Zhang J; Reverdatto S; Quadri N; DeVita RJ; Ramasamy R; Shekhtman A; Schmidt AM Sci Rep; 2016 Mar; 6():22450. PubMed ID: 26936329 [TBL] [Abstract][Full Text] [Related]
87. Immune cell signaling: a novel mechanistic model reveals new therapeutic targets. Sigalov AB Trends Pharmacol Sci; 2006 Oct; 27(10):518-24. PubMed ID: 16908074 [TBL] [Abstract][Full Text] [Related]
88. Development of receptor for advanced glycation end products-directed imaging of atherosclerotic plaque in a murine model of spontaneous atherosclerosis. Tekabe Y; Li Q; Rosario R; Sedlar M; Majewski S; Hudson BI; Einstein AJ; Schmidt AM; Johnson LL Circ Cardiovasc Imaging; 2008 Nov; 1(3):212-9. PubMed ID: 19808545 [TBL] [Abstract][Full Text] [Related]
89. [A cystein-dependent activation mechanism for the pro-inflammatory ligands of RAGE?]. Yatime L Med Sci (Paris); 2017 Mar; 33(3):351-354. PubMed ID: 28367826 [No Abstract] [Full Text] [Related]
90. The -429 T>C polymorphism of the receptor for advanced glycation end products (RAGE) is associated with type 1 diabetes in a Brazilian population. Picheth G; Heidemann M; Pedrosa FO; Chautard-Freire-Maia EA; Costantini CO; da Rocha Martinez TL; de Souza EM Clin Chim Acta; 2007 Aug; 383(1-2):163-4. PubMed ID: 17512509 [No Abstract] [Full Text] [Related]
91. RAGE in lung tumors. Franklin WA Am J Respir Crit Care Med; 2007 Jan; 175(2):106-7. PubMed ID: 17200506 [No Abstract] [Full Text] [Related]
92. Methylglyoxal: possible link between hyperglycaemia and immune suppression? Price CL; Knight SC Trends Endocrinol Metab; 2009 Sep; 20(7):312-7. PubMed ID: 19709901 [TBL] [Abstract][Full Text] [Related]
93. Receptor for advanced glycation end products facilitates host defense during Escherichia coli-induced abdominal sepsis in mice. van Zoelen MA; Schmidt AM; Florquin S; Meijers JC; de Beer R; de Vos AF; Nawroth PP; Bierhaus A; van der Poll T J Infect Dis; 2009 Sep; 200(5):765-73. PubMed ID: 19627249 [TBL] [Abstract][Full Text] [Related]
94. Endogenous secretory RAGE as a potential biochemical screening tool for erectile dysfunction. Emanuele E; Bertona M Med Hypotheses; 2006; 67(3):668-9. PubMed ID: 16750897 [No Abstract] [Full Text] [Related]
95. Factors associated with serum high mobility group box 1 (HMGB1) levels in a general population. Fukami A; Adachi H; Yamagishi S; Matsui T; Ueda S; Nakamura K; Enomoto M; Otsuka M; Kumagae S; Nanjo Y; Kumagai E; Esaki E; Murayama K; Hirai Y; Imaizumi T Metabolism; 2009 Dec; 58(12):1688-93. PubMed ID: 19616266 [TBL] [Abstract][Full Text] [Related]
96. Expression of advanced glycation end products and their receptor in skin from patients with systemic sclerosis with and without calcinosis. Davies CA; Herrick AL; Cordingley L; Freemont AJ; Jeziorska M Rheumatology (Oxford); 2009 Aug; 48(8):876-82. PubMed ID: 19542215 [TBL] [Abstract][Full Text] [Related]
97. Involvement of RAGE and Oxidative Stress in Inflammatory and Infectious Skin Diseases. Guarneri F; Custurone P; Papaianni V; Gangemi S Antioxidants (Basel); 2021 Jan; 10(1):. PubMed ID: 33435332 [TBL] [Abstract][Full Text] [Related]
98. Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial-derived S100B protein. Cirillo C; Sarnelli G; Esposito G; Grosso M; Petruzzelli R; Izzo P; Calì G; D'Armiento FP; Rocco A; Nardone G; Iuvone T; Steardo L; Cuomo R Neurogastroenterol Motil; 2009 Nov; 21(11):1209-e112. PubMed ID: 19558426 [TBL] [Abstract][Full Text] [Related]
99. Scavenger receptor control of chromogranin A-induced microglial stress and neurotoxic cascades. Hooper C; Fry VA; Sevastou IG; Pocock JM FEBS Lett; 2009 Nov; 583(21):3461-6. PubMed ID: 19800883 [TBL] [Abstract][Full Text] [Related]